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New Initiatives at The Rockefeller University
In fulfillment of its mandate for excellence and cogency in research, The
Rockefeller University has launched a set of new initiatives in fields of
biochemistry and molecular biology, which encompass genetics, cell
biology, and neurobiology.
These revolutionary frontiers for biological and medical science
relate to problems of cancer, reproduction, food supply, brain science,
mental disease, genetic abnormalities, and many degenerative disorders
caused by agents ranging from viruses to parasites. The research under
taken will augment worldwide progress in agriculture, medicine, and
public health.
Seven new research laboratories are being established in the brief
period between r 98 r and r 98 3. Appointment of the extraordinarily tal
ented leaders of these new laboratories, along with their many gifted
young colleagues, constitutes the most important surge of first-rank
investigators onto the campus during the past 20 years. The opportunity
for this surge stems in part from the retirement or death of some of the
University's most notable figures. As always, new laboratories call for
new levels of material commitment even at a time when the University
as a whole is under a stringent discipline in its growth.
To supplement available private and public support, the University
needs $ 3 5 million over the next two years to underwrite new initiatives
in these fields. This funding would endow professorships, support part
of the new and ongoing program for young investigators, and help meet
the cost of urgent modernization of research facilities and equipment.
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Molecular Biology-the New Frontier
To understand the emerging revolutionary opportunities in biology and
medicine, which are central to the University's New Initiatives, it is
important to grasp the overall perspectives of molecular biology. This
modern science is organized around the principle that, in order to
understand the complexities of living organisms, it is necessary to
understand the very basic constituents- molecules-which form cells
and, in turn, structure tissues and entire organisms. Investigations at
the molecular level are aimed at the fundamental building blocks of life.
These are, in themselves, complex biochemical structures.
Molecular biology emerged from the successful research by many
laboratories in biochemistry and genetics in the late 1930s and r 940s.
Perhaps the most notable landmark came from The Rockefeller Insti
tute, with the discovery in r 944 by Avery, Macleod, and McCarty that
the chemical basis of heredity is DNA. The seminal quality of the molec
ular approach was deepened in 1953 with Watson and Crick's picture of
the double-helix structure of DNA.
The double-helix DNA comprises two long thin chains twisted about
each other in a regular manner, like a double spiral staircase. Each chain
is built of smaller units (called nucleotides) that are cross-connected by a
"lock-and-key" pairing of single units on each chain. The overall
sequence of the units in a chain constitutes the genetic code.
The fundamental "words" of the genetic code were found to be
groupings of three nucleotides. These "code words" pass their instruc
tions first to so-called messenger RNA molecules and then to the key
building blocks (amino acids) in the cell. They direct the amino acids to
line up and combine in a particular sequence, forming specific proteins
of the cell in a unique order. This specific sequencing is what makes, for
example, the protein in our hair-coded by one gene-different from the
protein in our red blood cells, coded by another gene.
A ware that the sequence of nucleotides is the code that determines
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ultimately the character of genetic material, and by using procedures to
move genes around, investigators discovered a new picture. This picture
revealed more about the, detailed structure of genes and the elements
controlling their functions.
Later, when a way to synthesize proteins in the laboratory was dis
covered, the path to determining the genetic code was opened. Subse
quently, the precise meanings of the "code words"-the triplets of nu
cleotides-were revealed. Although protein synthesis is complicated, the
code was found to be universal. With only minor variations of "dialect,"
the same code appears in all living forms: microbial, plant, and animal.
This fact has profound implications for understanding the interrelation
ship of living matter and the evolutionary history of life on our planet.
Large areas of research on cells were soon clarified by this intellectual
revolution. Simple bacteria could be understood more readily; human
cells (or "eukaryotic" cells, i.e., cells with nuclei) are far more difficult
because cells in higher forms of life-including humans -have so much
more DNA than bacteria. The power of genetic studies was still so
limited in the early r 970s that further detailed analysis of DNA in higher
forms seemed remote. It was at this juncture that critically needed tech
niques were developed.
Molecular biology and biochemistry are on the frontiers of exciting
new horizons. For example, slight differences in DNA sequences (called
DNA polymorphisms) can be used to analyze and map the human chro
mosome. Such maps will lead, in turn, to deeper knowledge of many
diseases-from genetic disorders to cancer and aging.
These molecular, biochemical perspectives also will pave the way
toward better understanding of the brain and nervous system, building
the next stages of advanced agricultural production, and fathoming the
causes of a broad array of diseases for which there is presently no effective
approach to prevention or cure. Yet the accomplishment of this funda
mental research-and the innovations that will be based upon it-will
depend both on expansion of the tools in hand and on invention of new
concepts and techniques.
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Scientific Leadership for New Initiatives
In planning research initiatives and carefully selecting the leaders for
new laboratories, the University has three goals. First, to sustain the
University's mission of fundamental research. Second, to seize those
research opportunities that relate directly to major unsolved human
problems-fostering the applications that, over the next generation, will
make a genuine difference to the world. Third, to advance our research
leadership by adding a new generation of gifted scientists, replacing
those who have retired recently or who will retire during the next
decade.

Biochemical Genetics
One initiative is a new laboratory headed by Professor Robert G.
Roeder, who was the James S. McDonnell Professor in Biochemical
Genetics at Washington University School of Medicine in St. Louis.
His research activities are directed toward answering key questions
about the molecular basis of processes such as (a) cell growth and prolif
eration (e.g., what are the mechanisms in the early development of the
embryo?); (6) cell differentiation (e.g., what causes a liver cell to be dif
ferent from a heart cell?); and (c) the infection and transformation of
mammalian cells by DNA tumor virus (e.g., what are the controls in cells
that relate to the mechanisms of cancer?).
The cellular and viral genes that affect these processes are controlled
in part at the level of transcription ( the first step in the readout of
genetic information, from DNA to RNA). Dr. Roeder's work has focused
largely on an analysis of the biochemical mechanisms that are involved
in this process for individual genes.
Dr. Roeder's pioneering work in eukaryotic transcription (i.e., in
cells with nuclei, as in human cells) began while he was a graduate stu
dent at the University of Washington. This work led to the first isola-
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tion and characterization of the family of enzymes that directly copy
genetic information from DNA. On the basis of such fundamental work
on the eukaryotic transcription machinery, he was awarded the Ameri
can Chemical Society's Eli Lilly Award in Biological Chemistry in r 977.
Dr. Roeder's studies complement and allow extension of work on
gene structure and function already under way in many other labora
tories at The Rockefeller University and elsewhere. For example, the
ability to introduce specific mutations into genes (via recombinant DNA
technology) has allowed the delineation of the DNA sequences that are
important for expression and regulation. However, for most genes, such
experiments do not readily allow the identification of the regulatory fac
tors (presumably protein) that interact with and control these genes.
The approaches in Dr. Roeder's laboratory allow direct identification of
such factors and are necessary for fully understanding the mechanisms
involved in gene control.
The power and elegance of this approach have been amply demon
strated for bacterial genes and appear to be equally promising for human
genes. Ultimately, this line of research should clarify the reasons for
developmental abnormalities and enhance the explanation of the causes
of aging and cancer.

Organic Chemistry and Biochemistry
The initiative in organic chemistry and biochemistry is a new laboratory
headed by Professor Emil Thomas Kaiser. Dr.· Kaiser was at the Univer
sity of Chicago as the Louis Block Professor in the Departments of
Chemistry and Biochemistry. His research is focused on the actions of
enzymes.
In future biomedical research, a major concern will be capitalizing
on the extensive progress that has been made during the past 40, years in
understanding the molecular architecture of enzymes-the catalysts that
make it possible for us to do our daily tasks. The Rockefeller has a long
tradition in this field; the coming years will see the fruits of past invest-
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ment in such basic research. Significantly, Professor Kaiser came to the
University with a distinguished record of accomplishment in this specific area.
He has applied his early training at Harvard in physico-organic
chemistry to explaining the mechanisms by which enzymes selectively
foster certain reactions in the body. For example, he has studied pan
creatic enzymes, the enzymes concerned with blood pressure, and
enzymes from the cardiac muscles and from the lung. The "active
centers" of each of these molecules are being defined chemically, and
methods of enhancing or reducing their biological "activities" are being
developed. The work addresses the many diffi�ult problems in under
standing the relationships between the structure of a substance and the
substance's function in the body.
Professor Kaiser has extended such studies to the formation of pro
teins with new catalytic functions. In these innovative experiments, he
took an enzyme that facilitated the reaction of water with proteins and
coupled it to an organic compound that gave the combination a catalytic
o
activity toward materials that react with oxygen (such as those fund
in
human cells). A new species of catalyst was made; he had achieved an
artificial chemical hybrid. The preparation of new catalysts in this man
ner offers promise of application in industry as well as in biology and
medicine.
Further, Dr. Kaiser has been exploring the synthesis, from elemen
tary chemicals, of biologically active components. Proteins are polypep
tides built from amino acid building blocks, and peptides now can be
synthesized effectively by laboratory methods devised, in considerable
part, by Bruce Merrifield at The Rockefeller University. Professor
Kaiser is making ingenious use of these new synthetic approaches in the
preparation of new peptides that, for instance, can inhibit enzymes,
bind lipids (fats), prevent the formation of kidney stones, and prepare
new hormonal agents.
These efforts illustrate the enormous opportunities for achieving,
through organic chemistry and biochemistry, a fundamental under-
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standing of intricate living systems. The University provides a stimulat
ing context for Dr. Kaiser's efforts, working with both laboratory scien
tists in related fields and physicians whose patients have diseases that
must be understood more fully in chemical terms.

Plant Molecular Biology
The study of plants has been seminal in the history of biology-both as a
science and as a technology-from the traditional medicines derived
from plants through Mendel's revolutionary work on genetics to the
modern "green revolution." Numerous early and important discoveries
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Nam-Hai Chua

at The Rockefeller Institute for Medical Research were based upon plant
systems and extracts. The University intends to sustain its coherence as
an institution devoted to the sciences-of-life by maintaining a vigorous
program, in modern terms, in plant biology.
Nam-Hai Chua, born in Singapore and educated at Harvard, was
promoted to full professor in July r 98 r and organized a major new labo
ratory in plant molecular biology. Professor Chua is a cell and molecular
biologist who has made contributions to the understanding of photo
synthesis, chloroplast biogenesis, and plant gene structure and regula
tion. His special interest is the chloroplast, an organelle in the cells of
green plants that is important to all life because of its role in photo
synthesis. Energy from sunlight is trapped in the chloroplast and uti
lized in the manufacture of complex organic materials, particular! y
sugar, from simple inorganic substances.

IO

Dr. Chua has addressed himself to one of the long-standing puzzles
in cell biology: how are· needed proteins transported from their sites of
synthesis elsewhere in the cell to subcellular organelles, such as chloro
plasts, which have only a limited capacity to produce ,their own
proteins?
His current interest is plant gene structure and regulation. He is
investigating the mechanisms by which the gene that codes for the
chloroplast enzyme (ribulose diphosphate carboxylase) is differentially
regulated. This enzyme, found everywhere in green plants, is the most
abundant protein on earth. It is used for carbon dioxide fixation, the key
reaction in photosynthesis. It makes up 50% of the soluble protein in
plants such as soybean, and is present to a lesser extent in other plants
such as maize and sorghum, which are major food crops. Dr. Chua is
attempting to identify the gene control regions for this enzyme, which
would have substantial benefits for agriculture.

Molecular and Cellular Parasitology
Because parasitic diseases have not been a significant problem for citi
zens of the United States-except for travelers and our armed forces sta
tioned abroad-research on these diseases has never received a high prior
ity from public or private sponsors. Nonetheless, in global terms,
parasitic illness ·and death are probably the leading health problem.
Malaria alone kills a million children, infects about 200 million adults
each year, and puts about r. 8 billion people at risk. Trypanosomiasis
and schistosomiasis, among many others, also are critically important
threats to human health and domesticated animals throughout develop
ing countries.
Accordingly, the University has always devoted attention to this
international problem-from pioneering work early in this century on
cattle fever and hookworm, as well as on yellow fever and sleeping sick
ness, to the recent discovery by William Trager that may pave the way
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for a vaccine against malaria. Field work has been carried out interna
tionally, from South America and the Caribbean to India and China, and
throughout Europe and Africa.
George A. M. Cross, born in England and educated at Cambridge,
came to the University from the Wellcome Research Laboratories
(Kent), where he headed the Department of Immunochemistry, which is
concerned with parasitic infections. Previously he was a member of the
biochemical parasitology unit of the Medical Research Council at Cam
bridge. His new laboratory at The Rockefeller U�iversity will concen
trate on molecular parasitology.
Dr. Cross's approach is to study parasitism as a disease process and to
learn the underlying mechanisms of parasitism. These diseases go
through specific sets of developmental changes during each life cycle. At
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each stage, the parasite must express certain genes to facilitate its func
tion. Decoding these special steps of parasitic action will allow the
development of very spe�ific agents for the most effective disruption of
the disease process. Investigating the nature of stage-specific genes, the
genetic structure and organization, and the expression of parasite-spe
cific proteins-all should provide much greater insight into the use of
chemical agents capable of lethal action on specific parasitic stages. It
may also prove feasible to produce immunological agents capable of in
terrupting the parasite-host relationship and preventing infection.
This new line of research has recently been made possible by the
rapid and revolutionary growth in research technology. To investigate
the devastating human parasitic diseases at the cellular and subcellular
levels, and now at the molecular level, requires analysis of parasite gene
expression. Recombinant DNA technology, monoclonal antibodies, and
other recent molecular biological advances are eminently suited to this
work, and Dr. Cross has mastered these new techniques.

Biology of Skin Diseases
Skin, the largest organ of the body, has yet to be studied scientifically
with the scope that it merits. Cancer, aging, disfiguring skin problems
such as psoriasis and burns, and hazardous environmental' pollutants
that enter the body through the skin-these suggest the breadth of bio
logical, medical, and occupational problems related to the skin. Yet
dermatology rarely has received the attention of first-rank medical inves
tigators. Accordingly, as the University considered biomedical fields
that were ripe for attack in our Hospital, this area appeared promising.
We concluded that there was an unusual opportunity for creative efforts
on skin disease and identified a distinguished individual who could
organize a sophisticated approach to research in this area.
David Martin Carter came to the University in the summer of r 98 r
from Yale University School of Medicine where he had been Professor of
Dermatology. After graduating from Dartmouth, he earned an M. D. at
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Harvard and a Ph.D. in molecular biology at Yale (while serving as a
Howard Hughes Medical Investigator). In a remarkable way, he com
bines the necessary laboratory expertise of biochemical analysis with the
clinical experience required to investigate disabling and lethal skin
afflictions.
During the past year he has recruited a group of young collabora
tors- all with a comparable mix of medical and scientific training. He
has established strong links with our neighbors, the Memorial Sloan
Kettering and New York Hospitals, which have many patients in their
dermatological services. The laboratory's studies of environmental
impact on skin function deal primarily with damage resulting from
exposure to chemicals, drugs, and radiation.

Chromosomes of peripheral blood lymphocytes, differentially stained to show sister chromatids.
Exchanges between chromatids, promoted by DNA damage, are evident.

Dr. Carter's new initiatives-ranging from studies of damage to the
DNA of skin cells to the treatment of various skin disorders-will help to
build a firm foundation for this domain of medicine. The environment
at Rockefeller University provides Dr. Carter and his colleagues with
the opportunity to bridge the barriers that tend to separate laboratory
investigations from studies of hospitalized and ambulatory patients with
skin diseases.
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Neurobiology
The neurosciences are one of the most dramatic and important frontiers
for research in the coming decades. Understanding ,how the brain devel
ops and functions, eliminating psychological (psychiatric) disorders,
preventing and treating diseases of the brain and nervous system, and
ascertaining the limits of brain function are the ambitious goals that, for
the first time, are becoming feasible through the application of modern
biological tools for research. The University has a long record of accom
plishment in these fields and continues to assign a high priority to this
general area.
Torsten Wiesel, M.D., comes to the University in early 1983 from
the Harvard Medical School where he has been Robert Winthrop Profes
sor and Chairman of the Department of Neurobiology. Co-recipient of
the Nobel Prize in r98 r, Dr. Wiesel and his colleagues have been pio
neers in neurophysiology-carrying out pioneering studies of the cells in
the brain that relate to vision.
Dr. Wiesel and his group of gifted young collaborators-including
neuroanatomists, cell biologists, and biochemists- offer remarkable
complementarity to our ongoing efforts in the neurosciences, from brain
molecular biology to animal behavior. For example, Dr. Wiesel's cur
rent research includes "cutting edge" work on the study of methods of
tissue culture that will permit analysis of single visual cells in isolation.
Furthermore, the group exploits the �ntire range of modern instru
ments-from the electron microscope to computer graphics-in trying to
reveal the elegant networks and ensembles that the brain uses to process
information.

Neurochemistry
As Torsten Wiesel approaches the brain by examining in detail the pro
cesses of using visual information that comes from outside, the leader of
another initiative approaches the functions of the brain by exploring the
chemistry of its inner workings.
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Paul Greengard comes to the University rn mid- 1983 from Yale
University Medical School, where he has been Henry Bronson Professor
of Pharmacology. He is one of the leading neurochemists in the world,
and has attracted many talented students.
During the past decade, Dr. Greengard has made a series of discov
eries about the biochemistry of the brain that have provided a conceptual
framework for understanding the functioning of the nervous system in
molecular terms. He demonstrated that certain pharmacological and
clinical actions (both therapeutic and toxic) of several major classes of
psychoactive drugs-including common antipsychotic, hallucinogenic,
and antidepressant drugs-can be explained in terms of selective chemi
cal actions. This work has provided a practical new approach to the
development, by pharmaceutical companies, of drugs that act on the
nervous systern.
Greengard's work has had an impact on many branches of physiol
ogy, regulatory biology, and medicine. One of his results, formulated
about ro years ago, provides an explanation of how a single key com
pound can produce an enormous variety of biological effects. According
to his widely accepted hypothesis, this chemical compound activates an
enzyme present in the target tissues, and the specificity of the biological
effects lies in the nature of the substrate for the enzyme in the target
tissue. This approach is now being extended to focus on the mechanisms
of action of environmental toxins-and of alcohol-on the brain.

The Financial Challenge for Scientific Opportunity
In formulating a program for New Initiatives, requiring $35 million in
private support over two years, the University has three components in
mind. First, $ IO. 5 million would be used as endowment to establish
professorships for these distinguished members of the faculty, the lead
ers of the new laboratories. Subject to consultation with donors, chairs
may be named to honor ·individuals or organizations.
Second, $ r 4. 5 million would be directed toward the support of out
standing young investigators- ranging from advanced doctoral students
through postdoctoral fellows and assistant professors. This fund would
provide core support for research initiatives by young scientists at a time
when federal grants for these purposes are declining. Salaries, benefits,
and technical support will be allocated, at the discretion of the Presi
dent, for research projects recommended by heads of laboratories.
Finally, $ r o million would be directed to meeting the start-up costs
of the seven new laboratories, including the modernization of research
facilities, the purchase of scientific equipment, and data-handling sys
tems required for the research. Such capital investments are indispens
able for modern research, but the federal government is unlike! y to pro
vide any funding for these purposes.
An Investment in Talent. The need to endow and name professorships
grows directly from the University's long-standing tradition and current
fund-raising goals. The institution's policy is that all tenured members
of the faculty (the heads of laboratories) are paid entirely from endow
ment income. Working full-time on a r 2-month basis, these senior sci
entists are free from the concerns that most faculty members elsewhere
face in seeking partial grant support for their own salaries. This has fos
tered greater independence and flexibility, resulting over the years in
shifts of emphasis that might otherwise not have occurred and that have
proved to be highly inventive.
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To sustain this productive tradition against the pressure of rising
costs, the University must supplement its endowment. Since 197 r, one
of the highest priority fund-raising objectives has been to add endow
ment for senior faculty, and a number of grants have been received for
this purpose. During the next few years, with the renewal of several sci
entific fields on the campus, it will be even more important to assure the
stability of support for our scientific leadership. Each chair requires$ r. 5
million to endow; the capital is invested and a portion of the annual
income is used to preserve the purchasing power of the endowment.
The Laboratory and Technology of Science. Typically, a major new labora
tory requires a substantial investment in start-up costs. Upgrading a
laboratory-even space that has been used recently by active investiga
tors- usually means extensive renovation to meet the special needs of the
new group. Far from a routine "remodeling," the task is to design a
research facility in a specialized fashion, meeting sophisticated standards
for research. Changes also are mandated by governmental regulations on
biological and chemical work in a safe environment. Typically, renova
tion costs are not less than $r oo per net square foot, and a major labora
tory usually requires about 6,oqo net square feet of space. Therefore, the
total cost of renovation for one laboratory is at least$600,000.
In addition, purchases of new and costly scientific equipment are
often required. For example, major instruments (such as a nuclear mag
netic resonance spectrometer or an electron microscope-each costing
around $3 5o,ooo) are crucial to the research effort. In many cases, par
ticular! y during the past decade, even distinguished investigators have
been unable to purchase new instruments with federal funding. Com
puting and related data collection are also essential for nearly all
research, and federal support for computers continues to be extremely
scarce. New equipment for a laboratory usually requires not less than
$500,000 and can be as much as$ r,000,000.
Assuring Flexibility and Investigative Freedom. Although leading scientists
continue to be able to attract government funding for their programs,

Neu· Initiatives in Biological and Medical Science

some "core support" for the laboratory must be provided to ensure the
flexibility needed for exploratory studies. Such core financing may be
used as a revolving fund to support parts of the salaries of postdoctoral
fellows and younger faculty who are pursuing pilot studies, most of
which lead, in time, to federal grants. Also, core support frequently
covers the replacement of major parts for scientific instruments and
other emergencies that simply cannot be budgeted or anticipated in
either federal grants or the University's tight fiscal planning. Require
ments for core support vary widely from lab to lab and from year to year.
Usually, that support would be not less than $200,000 per year and
might reach $ 3 5 o, ooo per year for a large laboratory. Such a laboratory
usually receives three times that level of funding from federal grants.
Thus, private support permits great leverage in allowing new ideas to be
pursued by providing start-up costs and by buffering shifts in availabil
ity of government funds.

Summary
The capital costs associated with the establishment of seven laboratories
under the University's New Initiatives Program are as follows:
Professorships. Endow and name distinguished professorships for scientists who will lead new laboratories
(seven at $ r. 5 million)

$ ro. 5 million

Young Investigators and Fund for New Initiatives. Sup
port flexible funding for young investigators and new
projects; assist in core support of new laboratories for
five years

$ 14. 5 million

Research Equipment and Facilities. Partial support for
purchase of scientific. equipment and upgrading
research facilities required to start new laboratories

$ ro million

Total
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$ 35 million

March 1983

